Fraility index and its anaesthetic implications
frailty index perioperative anaesthesia outcomes
frailty perioperative outcomes surgery
frailty anesthesia postoperative delirium cognitive
frailty assessment Clinical Frailty Scale perioperative

Table 4. Tools to Detect Frailty <table><thead><tr><th>Assessment Tool</th><th>Comments</th></tr></thead><tbody><tr><td>Fried score</td><td>Well-established physical frailty tool based on data from the Cardiovascular Health Study; often seen as a reference frame for studies of frailty in community-dwelling older adults; requires two procedures/measures (gait speed and grip strength) and answers to three questions (relating to weight loss, level of exhaustion, and amount of physical activity); can identify "prefrail" individuals (42).</td></tr><tr><td>Clinical Frailty Scale (Note: A larger 70-item assessment tool called the Frailty Index is also available.)</td><td>Based on data from the Canadian Study of Health and Aging; seven-point scale; predictive of future events including mortality; easy to employ in routine clinical practice (43).</td></tr><tr><td>FRAIL score</td><td>Well-validated in multiple population groups; sensitivity and specificity similar to that of the Fried scale. Comprises only five questions (no procedures) covering fatigue, climbing stairs, walking, number of illnesses, and weight loss (44).</td></tr></tbody></table>

<table><thead><tr><th>COR</th><th>LOE</th><th>RECOMMENDATION</th></tr></thead><tbody><tr><td>2a</td><td>B-NR</td><td>1. In all patients ≥65 years of age and in those <64 years with perceived frailty who are undergoing elevated-risk NCS, preoperative frailty assessment using a validated tool can be useful for evaluating perioperative risk and guiding management.<sup>1-5</sup></td></tr></tbody></table>

Summary : This figure outlines a structured approach for screening malnutrition and assessing frailty and/or sarcopenia, categorizing assessment methods into clinician questions, physical exam findings, and objective measures. flowchart: # Central Node : • "Screen for Malnutrition & Assess for frailty and/or sarcopenia" (rounded rectangle, orange background) # Assessment Categories : ## Clinician questions : • Karnofsky Performance Scale • Clinical Frailty Scale • Activities of Daily Living • Pediatric populations: – Royal Free Hospital-Nutrition Prioritizing Tool – Lansky play performance scale – Fried-exhaustion, shrinkage, Pediatric Quality of Life Inventory ## Physical exam findings : • Muscle wasting – wasting at the temples, clavicle, shoulder, scapula/abs, quadriceps, interosseous muscle between the thumb and forefinger • Use of a walking aid • Inability to stand up from the chair independently or getting off the exam table independently, slowness ## Objective measures : • CT scan L3 skeletal muscle index • Liver frailty index • Handgrip strength • 6 minute walk test • 4 meter gait speed • Triceps skin-fold thickness (pediatrics) # Layout : • The central node is on the left, with three columns to the right, each headed by an icon and a category title. • Each column lists specific tools or findings under its category. Analysis : • The figure provides a comprehensive, multi-modal framework for assessing malnutrition, frailty, and sarcopenia, integrating subjective clinician assessments, physical examination findings, and objective quantitative measures. The inclusion of pediatric-specific tools highlights adaptability for different populations. The structure encourages a systematic, multi-pronged evaluation.
frailty preoperative assessment surgical outcomes meta-analysis
| Criterion | Operational Definition |
|---|---|
| Unintentional weight loss | >4.5 kg in the past year |
| Self-reported exhaustion | Positive answer on CES-D depression scale |
| Low physical activity | Lowest quintile of kcal/week expended |
| Slowness of gait | Slowest quintile for 15-foot walk |
| Reduced grip strength | Lowest quintile by gender and BMI |
FI = (number of deficits present) / (total deficits assessed)

| Tool | Description | Time | Best Use |
|---|---|---|---|
| Clinical Frailty Scale (CFS) | 9-level pictorial scale (1=very fit, 9=terminally ill). Score ≥4 = frail | <1 min | Preferred - most feasible preoperatively |
| Modified Frailty Index (mFI) | 11-item index derived from the Canadian Study of Health & Aging | 5-10 min | Widely validated in surgical databases |
| FRAIL Scale | 5 questions: Fatigue, Resistance, Ambulation, Illness, Loss of weight | <3 min | Simple screening, no procedures needed |
| Edmonton Frail Scale | 11-item including clock drawing + Timed Up and Go | 5 min | Can be administered by non-medical staff |
| Robinson Criteria | Mini-Cog ≤3 + albumin ≤30 g/L + falls + HCT <35%; OR TUG ≥15s + ADL dependence + Charlson ≥3 | 5-10 min | Validated specifically for surgical patients |
| Groningen Frailty Indicator (GFI) | 15-item questionnaire | 5 min | Validated for arthroplasty patients |

| Drug | Change in Frail/Elderly | Clinical Implication |
|---|---|---|
| Propofol | Nearly 50% lower blood levels needed; reduced rapidly-equilibrating peripheral compartment volume; reduced systemic clearance | Higher risk of apnoea and hypotension; reduce induction dose significantly |
| Etomidate | Decreased initial volume of distribution with aging | Lower doses required |
| Fentanyl/Alfentanil/Sufentanil | Primarily pharmacodynamic enhancement; dose requirements 50% lower | Reduce opioid doses by ~50% |
| Benzodiazepines | Increased volume of distribution (more body fat); prolonged elimination half-lives; enhanced pharmacodynamic sensitivity | Midazolam requirements ~50% less; half-life prolonged ~50%; avoid if possible due to delirium risk |
| Succinylcholine | Response not significantly altered | Standard dosing |
| Pancuronium | Decreased renal clearance | Prolonged recovery; avoid |
| Rocuronium/Vecuronium | Decreased hepatic excretion; prolonged elimination half-life | Prolonged duration |
| Atracurium/Cisatracurium | Not significantly affected by age | Preferred choice in frail patients |
| Risk Group | Score | POD Incidence |
|---|---|---|
| Low | 0 | 3.8% |
| Intermediate | 1-2 | 11.1% |
| High | 3-4 | 37.1% |
| Domain | Key Recommendation |
|---|---|
| Preoperative | Use CFS or validated frailty tool; perform CGA; optimise nutrition (albumin); review polypharmacy; stop unnecessary anticholinergics and benzodiazepines preoperatively |
| Choice of technique | Regional anaesthesia preferred where feasible to reduce delirium, opioid requirements, and haemodynamic instability |
| Induction | Reduce propofol induction dose (~50% of standard); slower titration; anticipate hypotension |
| Maintenance | Prefer rapidly-eliminated volatiles (sevoflurane/desflurane) or TIVA with careful titration; use processed EEG monitoring (BIS/entropy) to avoid over-anaesthesia |
| Muscle relaxants | Prefer atracurium or cisatracurium; use quantitative neuromuscular monitoring; ensure full reversal |
| Opioids | Reduce doses by ~50%; use multimodal analgesia; minimise opioid burden postoperatively |
| Benzodiazepines | Avoid premedication with benzodiazepines; strong delirium risk |
| Temperature | Active warming - frail patients are more susceptible to hypothermia |
| Haemodynamics | Avoid prolonged hypotension; target organ-protective MAP; judicious fluid therapy |
| Postoperative | Non-pharmacological delirium prevention bundles (HELP protocol); early mobilisation; adequate pain control; optimise sleep |
| Palliative/Goals of care | Frailty supports earlier palliative care involvement and shared decision-making about the goals of surgery (Miller's Anesthesia, 10e) |